Emerging Research in Renal Cell Carcinoma
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 173
Special Issue Editor
Special Issue Information
Dear Colleagues,
Renal cell carcinoma (RCC) is an area of active investigation, with ongoing efforts to improve the diagnosis, treatment, and management of this disease. Previous studies have focused on identifying new biomarkers for early detection, developing targeted therapies that improve outcomes and reduce side effects, and exploring the role of immune checkpoint inhibitors in RCC treatment. Recent areas of interest include the use of combination therapies, the development of predictive models to guide treatment decisions, and the use of liquid biopsies to monitor disease progression. Overall, these studies hold promise for improving outcomes for patients with RCC and advancing our understanding of this complex disease, which is the aim of this Special Issue.
Dr. Giandomenico Roviello
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- renal cell carcinoma
- biomarkers
- targeted therapies
- immune checkpoint inhibitors
- liquid biopsies
